Human Gene ARHGAP26 (uc011dbj.2)
  Description: Homo sapiens Rho GTPase activating protein 26 (ARHGAP26), transcript variant 1, mRNA.
RefSeq Summary (NM_015071): Interaction of a cell with the extracellular matrix triggers integrin cell surface receptors to begin signaling cascades that regulate the organization of the actin-cytoskeleton. One of the proteins involved in these cascades is focal adhesion kinase. The protein encoded by this gene is a GTPase activating protein that binds to focal adhesion kinase and mediates the activity of the GTP binding proteins RhoA and Cdc42. Defects in this gene are a cause of juvenile myelomonocytic leukemia (JMML). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2017].
Transcript (Including UTRs)
   Position: hg19 chr5:142,150,292-142,608,572 Size: 458,281 Total Exon Count: 23 Strand: +
Coding Region
   Position: hg19 chr5:142,150,327-142,602,011 Size: 451,685 Coding Exon Count: 23 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesModel Information
Methods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr5:142,150,292-142,608,572)mRNA (may differ from genome)Protein (814 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCHPRDLynxMalacards
MGIneXtProtOMIMPubMedReactomeTreefam
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: RHG26_HUMAN
DESCRIPTION: RecName: Full=Rho GTPase-activating protein 26; AltName: Full=GTPase regulator associated with focal adhesion kinase; AltName: Full=Oligophrenin-1-like protein; AltName: Full=Rho-type GTPase-activating protein 26;
FUNCTION: GTPase-activating protein for RHOA and CDC42.
SUBUNIT: Interacts with NYAP1, NYAP2 and MYO16 (By similarity). Binds to the C-terminus of PTK2/FAK1.
INTERACTION: Q6P5Z2:PKN3; NbExp=4; IntAct=EBI-1390913, EBI-1384335;
SUBCELLULAR LOCATION: Cell junction, focal adhesion (By similarity). Cytoplasm, cytoskeleton (By similarity). Note=Colocalizes with actin stress fibers and cortical actin structures (By similarity).
DISEASE: Defects in ARHGAP26 are a cause of juvenile myelomonocytic leukemia (JMML) [MIM:607785]. JMML is a pediatric myelodysplastic syndrome that constitutes approximately 30% of childhood cases of myelodysplastic syndrome (MDS) and 2% of leukemia. Chromosomal translocation t(5;11)(q31;q23) with MLL has been found in a JMML patient.
SIMILARITY: Contains 1 PH domain.
SIMILARITY: Contains 1 Rho-GAP domain.
SIMILARITY: Contains 1 SH3 domain.
WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/GRAFID291.html";
WEB RESOURCE: Name=Wikipedia; Note=Graf1 entry; URL="http://en.wikipedia.org/wiki/Graf1";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): ARHGAP26
CDC HuGE Published Literature: ARHGAP26
Positive Disease Associations: Body Height , Diabetes Mellitus, Type 2 , Neuroblastoma , Peroxidase , Triglycerides , Uric Acid
Related Studies:
  1. Body Height
    Caroline S Fox et al. BMC medical genetics 2007, Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project., BMC medical genetics. [PubMed 17903300]
    Adiposity traits are associated with SNPs on the Affymetrix 100K SNP GeneChip. Replication of these initial findings is necessary. These data will serve as a resource for replication as more genes become identified with BMI and WC.
  2. Diabetes Mellitus, Type 2
    Laura J Scott et al. Science (New York, N.Y.) 2007, A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants., Science (New York, N.Y.). [PubMed 17463248]
  3. Neuroblastoma
    , , . [PubMed 0]
           more ... click here to view the complete list

-  MalaCards Disease Associations
  MalaCards Gene Search: ARHGAP26
Diseases sorted by gene-association score: juvenile myelomonocytic leukemia* (700), juvenile myelomonocytic leukemia, somatic arhgap26-related* (100), myelodysplastic syndrome (3)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 14.32 RPKM in Whole Blood
Total median expression: 203.79 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -16.3035-0.466 Picture PostScript Text
3' UTR -2262.146561-0.345 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR013606 - IRSp53/MIM_homology_IMD
IPR011993 - PH_like_dom
IPR001849 - Pleckstrin_homology
IPR008936 - Rho_GTPase_activation_prot
IPR000198 - RhoGAP_dom
IPR001452 - SH3_domain

Pfam Domains:
PF00018 - SH3 domain
PF00169 - PH domain
PF00620 - RhoGAP domain
PF07653 - Variant SH3 domain
PF14604 - Variant SH3 domain
PF16746 - BAR domain of APPL family

SCOP Domains:
48350 - GTPase activation domain, GAP
50044 - SH3-domain
50729 - PH domain-like

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1UGV - NMR MuPIT


ModBase Predicted Comparative 3D Structure on Q9UNA1
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
      
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005096 GTPase activator activity
GO:0005515 protein binding
GO:0005543 phospholipid binding

Biological Process:
GO:0007165 signal transduction
GO:0007399 nervous system development
GO:0030036 actin cytoskeleton organization
GO:0043547 positive regulation of GTPase activity
GO:0051056 regulation of small GTPase mediated signal transduction

Cellular Component:
GO:0005575 cellular_component
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0005925 focal adhesion
GO:0030054 cell junction


-  Descriptions from all associated GenBank mRNAs
  AK123519 - Homo sapiens cDNA FLJ41525 fis, clone BRTHA2013942.
BC068555 - Homo sapiens Rho GTPase activating protein 26, mRNA (cDNA clone MGC:87468 IMAGE:30343863), complete cds.
AF141884 - Homo sapiens oligophrenin-1 like protein (OPHN1L) mRNA, complete cds.
KJ898442 - Synthetic construct Homo sapiens clone ccsbBroadEn_07836 ARHGAP26 gene, encodes complete protein.
AB463225 - Synthetic construct DNA, clone: pF1KA0621, Homo sapiens ARHGAP26 gene for Rho GTPase activating protein 26, without stop codon, in Flexi system.
CU686665 - Synthetic construct Homo sapiens gateway clone IMAGE:100023002 5' read ARHGAP26 mRNA.
KU178561 - Homo sapiens Rho GTPase activating protein 26 isoform 1 (ARHGAP26) mRNA, partial cds.
KU178562 - Homo sapiens Rho GTPase activating protein 26 isoform 2 (ARHGAP26) mRNA, complete cds, alternatively spliced.
AB014521 - Homo sapiens mRNA for KIAA0621 protein, partial cds.
AK095220 - Homo sapiens cDNA FLJ37901 fis, clone CD34C3000424, highly similar to Rho-GTPase-activating protein 26.
BC021059 - Homo sapiens Rho GTPase activating protein 26, mRNA (cDNA clone IMAGE:2967066).
HM037040 - Homo sapiens Rho GTPase activating protein 26 variant 3 (ARHGAP26) mRNA, partial cds, alternatively spliced.
AK298708 - Homo sapiens cDNA FLJ55136 complete cds, moderately similar to Rho-GTPase-activating protein 26.
HZ473906 - WO 2016002844-A/20: ANTI-INVASIVE/ANTI-METASTATIC DRUG FOR PANCREATIC CANCER CELL.
AK124521 - Homo sapiens cDNA FLJ42530 fis, clone BRACE3002420.
JD143771 - Sequence 124795 from Patent EP1572962.
JD153695 - Sequence 134719 from Patent EP1572962.
JD559127 - Sequence 540151 from Patent EP1572962.
JD172127 - Sequence 153151 from Patent EP1572962.
JD352706 - Sequence 333730 from Patent EP1572962.
JD248567 - Sequence 229591 from Patent EP1572962.
JD358831 - Sequence 339855 from Patent EP1572962.
JD241754 - Sequence 222778 from Patent EP1572962.
JD071770 - Sequence 52794 from Patent EP1572962.
JD251144 - Sequence 232168 from Patent EP1572962.
JD084814 - Sequence 65838 from Patent EP1572962.
JD515856 - Sequence 496880 from Patent EP1572962.
JD097192 - Sequence 78216 from Patent EP1572962.
JD050311 - Sequence 31335 from Patent EP1572962.
JD055766 - Sequence 36790 from Patent EP1572962.
JD235688 - Sequence 216712 from Patent EP1572962.
JD170046 - Sequence 151070 from Patent EP1572962.
JD044200 - Sequence 25224 from Patent EP1572962.
JD172185 - Sequence 153209 from Patent EP1572962.
JD506556 - Sequence 487580 from Patent EP1572962.
JD376920 - Sequence 357944 from Patent EP1572962.
JD353437 - Sequence 334461 from Patent EP1572962.
JD397486 - Sequence 378510 from Patent EP1572962.
JD353317 - Sequence 334341 from Patent EP1572962.
JD259564 - Sequence 240588 from Patent EP1572962.
HZ473903 - WO 2016002844-A/17: ANTI-INVASIVE/ANTI-METASTATIC DRUG FOR PANCREATIC CANCER CELL.
JD363684 - Sequence 344708 from Patent EP1572962.
JD314788 - Sequence 295812 from Patent EP1572962.
JD291968 - Sequence 272992 from Patent EP1572962.
JD429535 - Sequence 410559 from Patent EP1572962.
JD202210 - Sequence 183234 from Patent EP1572962.
JD292171 - Sequence 273195 from Patent EP1572962.
JD090990 - Sequence 72014 from Patent EP1572962.
JD562856 - Sequence 543880 from Patent EP1572962.
JD175304 - Sequence 156328 from Patent EP1572962.
JD074340 - Sequence 55364 from Patent EP1572962.
JD284660 - Sequence 265684 from Patent EP1572962.
JD205302 - Sequence 186326 from Patent EP1572962.
JD486038 - Sequence 467062 from Patent EP1572962.
JD494700 - Sequence 475724 from Patent EP1572962.
JD557070 - Sequence 538094 from Patent EP1572962.
JD300244 - Sequence 281268 from Patent EP1572962.
JD494178 - Sequence 475202 from Patent EP1572962.
JD552669 - Sequence 533693 from Patent EP1572962.
JD263086 - Sequence 244110 from Patent EP1572962.
JD297775 - Sequence 278799 from Patent EP1572962.
HZ473905 - WO 2016002844-A/19: ANTI-INVASIVE/ANTI-METASTATIC DRUG FOR PANCREATIC CANCER CELL.
JD095920 - Sequence 76944 from Patent EP1572962.
JD470518 - Sequence 451542 from Patent EP1572962.
JD124311 - Sequence 105335 from Patent EP1572962.
JD312220 - Sequence 293244 from Patent EP1572962.
JD312221 - Sequence 293245 from Patent EP1572962.
JD202294 - Sequence 183318 from Patent EP1572962.
JD166715 - Sequence 147739 from Patent EP1572962.
HZ473904 - WO 2016002844-A/18: ANTI-INVASIVE/ANTI-METASTATIC DRUG FOR PANCREATIC CANCER CELL.
JD073847 - Sequence 54871 from Patent EP1572962.
JD173790 - Sequence 154814 from Patent EP1572962.
JD043192 - Sequence 24216 from Patent EP1572962.
JD276096 - Sequence 257120 from Patent EP1572962.
JD225238 - Sequence 206262 from Patent EP1572962.
JD502590 - Sequence 483614 from Patent EP1572962.
JD048975 - Sequence 29999 from Patent EP1572962.
JD027065 - Sequence 8089 from Patent EP1572962.
JD035047 - Sequence 16071 from Patent EP1572962.
JD033967 - Sequence 14991 from Patent EP1572962.
AK092488 - Homo sapiens cDNA FLJ35169 fis, clone PLACE6012908.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q9UNA1 (Reactome details) participates in the following event(s):

R-HSA-194922 GAPs inactivate Rho GTPase:GTP by hydrolysis
R-HSA-194840 Rho GTPase cycle
R-HSA-194315 Signaling by Rho GTPases
R-HSA-162582 Signal Transduction

-  Other Names for This Gene
  Alternate Gene Symbols: GRAF, KIAA0621, NM_015071, NP_055886, O75117, OPHN1L, Q5D035, Q9BYS6, Q9BYS7, Q9UJ00, Q9UNA1, RHG26_HUMAN
UCSC ID: uc011dbj.2
RefSeq Accession: NM_015071
Protein: Q9UNA1 (aka RHG26_HUMAN or RH26_HUMAN)
CCDS: CCDS4277.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_015071.4
exon count: 23CDS single in 3' UTR: no RNA size: 9041
ORF size: 2445CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 5090.00frame shift in genome: no % Coverage: 100.00
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.